Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer

✍ Scribed by Razvan M Galalae; Alvaro Martinez; Tim Mate; Christina Mitchell; Gregory Edmundson; Nils Nuernberg; Stephen Eulau; Gary Gustafson; Michael Gribble; Gyoergy Kovács

• Book ID: 108148263
• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 122 KB
• Volume: 58
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2003.08.003